本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

2.47
+0.02000.82%
盤後2.35-0.1200-4.86%18:45 EDT
成交量:24.75萬
成交額:59.87萬
市值:6,017.69萬
市盈率:-0.43
高:2.52
開:2.46
低:2.36
收:2.45
資料載入中...
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/17

SEC問詢函

Form CORRESP - Correspondence
2024/07/17

SEC問詢函

Form CORRESP - Correspondence
2024/07/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]